ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $150,604 | -2.3% | 42,068 | +0.7% | 0.00% | – |
Q2 2023 | $154,161 | +16.6% | 41,778 | +4.6% | 0.00% | – |
Q1 2023 | $132,258 | -15.2% | 39,957 | -0.6% | 0.00% | -100.0% |
Q4 2022 | $155,929 | +73.3% | 40,188 | +8.6% | 0.00% | – |
Q3 2022 | $90,000 | +26.8% | 37,004 | +2.3% | 0.00% | – |
Q2 2022 | $71,000 | +91.9% | 36,170 | +78.5% | 0.00% | – |
Q1 2022 | $37,000 | -5.1% | 20,265 | -26.5% | 0.00% | – |
Q4 2021 | $39,000 | +25.8% | 27,576 | +56.6% | 0.00% | – |
Q1 2021 | $31,000 | +10.7% | 17,612 | +20.6% | 0.00% | – |
Q4 2020 | $28,000 | -45.1% | 14,603 | -31.4% | 0.00% | – |
Q3 2020 | $51,000 | -20.3% | 21,292 | -3.1% | 0.00% | – |
Q2 2020 | $64,000 | +82.9% | 21,978 | +82.0% | 0.00% | – |
Q1 2020 | $35,000 | -55.7% | 12,073 | -38.6% | 0.00% | – |
Q4 2019 | $79,000 | – | 19,652 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |